2012

54 publications

  • Bonnefond A, Clément N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A, Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O, Langenberg C, Bouatia-Naji N; The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Charpentier G, Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I, Jockers R, Froguel P.
    Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
    Nat Genet2012 Jan 29;44(3):297-301
  • Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D
    Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
    Lancet Neurol2012 Jul;11(7):589-96
  • Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S.
    The First Generation of ß-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy.
    Angew Chem Int Ed Engl2012 Nov 12;51(46):11606-10
  • Robert R, Reignier J, Tournoux-Facon C, Boulain T, Lesieur O, Gissot V, Souday V, Hamrouni M, Chapon C, Gouello JP; Association des Réanimateurs du Centre Ouest Group.
    Refusal of intensive care unit admission due to a full unit: impact on mortality
    Am J Respir Crit Care Med. 2012 May 15;185(10):1081-72012 May 15;185(10):1081-7
  • Czuczman MS, Fayad L, Delwail V, Cartron G, Jacobsen E, Kuliczkowski K, Link BK, Pinter-Brown L, Radford J, Hellmann A, Gallop-Evans E, DiRienzo CG, Goldstein N, Gupta I, Jewell RC, Lin TS, Lisby S, Schultz M, Russell CA, Hagenbeek A; 405 Study Investigators.
    Ofatumumab monotherapy in rituximab-refractory follicular lymphoma: results from a multicenter study.
    Blood2012 Apr 19;119(16):3698-704
  • Guilhot J, Baccarani M, Clark RE, Cervantes F, Guilhot F, Hochhaus A, Kulikov S, Mayer J, Petzer AL, Rosti G, Rousselot P, Saglio G, Saussele S, Simonsson B, Steegmann JL, Zaritskey A, Hehlmann R.
    Definitions, methodological, and statistical issues for phase III clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
    Blood2012 Jun 21;119(25):5963-71
  • Chomel JC, Sorel N, Guilhot J, Guilhot F, Turhan AG.
    BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemia.
    Blood2012 Mar 22;119(12):2964-5; author reply 2965-6
  • Hoffmann V, Baccarani M, Hasford J, Guilhot J, Saussele S, Rosti G, Guilhot F, Porkka K, Ossenkoppele G, Lindoerfer D, Simonsson B, Pfirrmann M, Hehlmann R.
    The EUTOS CML score aims to support clinical decision-making
    Blood2012 Mar 22;119(12):2966-7.
  • Fraineau S, Monvoisin A, Clarhaut J, Talbot J, Simonneau C, Kanthou C, Kanse SM, Philippe M, Benzakour O.
    The vitamin K-dependent anti-coagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner.
    Blood2012 Dec 13;120(25):5073-83
  • Rea D, Etienne G, Nicolini F, Cony-Makhoul P, Johnson-Ansah H, Legros L, Huguet F, Tulliez M, Gardembas M, Bouabdallah K, Rousselot P, Cayuela JM, Guilhot F, Mahon FX.
    First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia.
    Leukemia2012 Oct;26(10):2254-9
  • Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T, McKay GJ, Williams WW, Sadlier DM, Mäkinen VP, Swan EJ, Palmer C, Boright AP, Ahlqvist E, Deshmukh HA, Keller BJ, Huang H, Ahola AJ, Fagerholm E, Gordin D, Harjutsalo V, He B, Heikkilä O, Hietala K, Kytö J, Lahermo P, Lehto M, Lithovius R, Osterholm AM, Parkkonen M, Pitkäniemi J, Rosengård-Bärlund M, Saraheimo M, Sarti C, Söderlund J, Soro-Paavonen A, Syreeni A, Thorn LM, Tikkanen H, Tolonen N, Tryggvason K, Tuomilehto J, Wadén J, Gill GV, Prior S, Guiducci C, Mirel DB, Taylor A, Hosseini SM; DCCT/EDIC Research Group, Parving HH, Rossing P, Tarnow L, Ladenvall C, Alhenc-Gelas F, Lefebvre P, Rigalleau V, Roussel R, Tregouet DA, Maestroni A, Maestroni S, Falhammar H, Gu T, Möllsten A, Cimponeriu D, Ioana M, Mota M, Mota E, Serafinceanu C, Stavarachi M, Hanson RL, Nelson RG, Kretzler M, Colhoun HM, Panduru NM, Gu HF, Brismar K, Zerbini G, Hadjadj S, Marre M, Groop L, Lajer M, Bull SB, Waggott D, Paterson AD, Savage DA, Bain SC, Martin F, Hirschhorn JN, Godson C, Florez JC, Groop PH, Maxwell AP.
    New susceptibility Loci associated with kidney disease in type 1 diabetes.
    PLoS Genet. 2012 Sep;8(9):e1002921
  • Dastani Z, Hivert MF, Timpson N, Perry JR, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen LP, Fuchsberger C, Tanaka T, Morris AP, Small K, Isaacs A, Beekman M, Coassin S, Lohman K, Qi L, Kanoni S, Pankow JS, Uh HW, Wu Y, Bidulescu A, Rasmussen-Torvik LJ, Greenwood CM, Ladouceur M, Grimsby J, Manning AK, Liu CT, Kooner J, Mooser VE, Vollenweider P, Kapur KA, Chambers J, Wareham NJ, Langenberg C, Frants R, Willems-Vandijk K, Oostra BA, Willems SM, Lamina C, Winkler TW, Psaty BM, Tracy RP, Brody J, Chen I, Viikari J, Kähönen M, Pramstaller PP, Evans DM, St Pourcain B, Sattar N, Wood AR, Bandinelli S, Carlson OD, Egan JM, Böhringer S, van Heemst D, Kedenko L, Kristiansson K, Nuotio ML, Loo BM, Harris T, Garcia M, Kanaya A, Haun M, Klopp N, Wichmann HE, Deloukas P, Katsareli E, Couper DJ, Duncan BB, Kloppenburg M, Adair LS, Borja JB; DIAGRAM+ Consortium; MAGIC Consortium; GLGC Investigators; MuTHER Consortium, Wilson JG, Musani S, Guo X, Johnson T, Semple R, Teslovich TM, Allison MA, Redline S, Buxbaum SG, Mohlke KL, Meulenbelt I, Ballantyne CM, Dedoussis GV, Hu FB, Liu Y, Paulweber B, Spector TD, Slagboom PE, Ferrucci L, Jula A, Perola M, Raitakari O, Florez JC, Salomaa V, Eriksson JG, Frayling TM, Hicks AA, Lehtimäki T, Smith GD, Siscovick DS, Kronenberg F, van Duijn C, Loos RJ, Waterworth DM, Meigs JB, Dupuis J, Richards JB, Voight BF, Scott LJ, Steinthorsdottir V, Dina C, Welch RP, Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, McCulloch LJ, Ferreira T, Grallert H, Amin N, Wu G, Willer CJ, Raychaudhuri S, McCarroll SA, Hofmann OM, Segrè AV, van Hoek M, Navarro P, Ardlie K, Balkau B, Benediktsson R, Bennett AJ, Blagieva R, Boerwinkle E, Bonnycastle LL, Boström KB, Bravenboer B, Bumpstead S, Burtt NP, Charpentier G, Chines PS, Cornelis M, Crawford G, Doney AS, Elliott KS, Elliott AL, Erdos MR, Fox CS, Franklin CS, Ganser M, Gieger C, Grarup N, Green T, Griffin S, Groves CJ, Guiducci C, Hadjadj S, Hassanali N, Herder C, Isomaa B, Jackson AU, Johnson PR, Jørgensen T, Kao WH, Kong A, Kraft P, Kuusisto J, Lauritzen T, Li M, Lieverse A, Lindgren CM, Lyssenko V, Marre M, Meitinger T, Midthjell K, Morken MA, Narisu N, Nilsson P, Owen KR, Payne F, Petersen AK, Platou C, Proença C, Prokopenko I, Rathmann W, Rayner NW, Robertson NR, Rocheleau G, Roden M, Sampson MJ, Saxena R, Shields BM, Shrader P, Sigurdsson G, Sparsø T, Strassburger K, Stringham HM, Sun Q, Swift AJ, Thorand B, Tichet J, Tuomi T, van Dam RM, van Haeften TW, van Herpt T, van Vliet-Ostaptchouk JV, Walters GB, Weedon MN, Wijmenga C, Witteman J, Bergman RN, Cauchi S, Collins FS, Gloyn AL, Gyllensten U, Hansen T, Hide WA, Hitman GA, Hofman A, Hunter DJ, Hveem K, Laakso M, Morris AD, Palmer CN, Rudan I, Sijbrands E, Stein LD, Tuomilehto J, Uitterlinden A, Walker M, Watanabe RM, Abecasis GR, Boehm BO, Campbell H, Daly MJ, Hattersley AT, Pedersen O, Barroso I, Groop L, Sladek R, Thorsteinsdottir U, Wilson JF, Illig T, Froguel P, van Duijn CM, Stefansson K, Altshuler D, Boehnke M, McCarthy MI, Soranzo N, Wheeler E, Glazer NL, Bouatia-Naji N, Mägi R, Randall J, Elliott P, Rybin D, Dehghan A, Hottenga JJ, Song K, Goel A, Lajunen T, Doney A, Cavalcanti-Proença C, Kumari M, Timpson NJ, Zabena C, Ingelsson E, An P, O’Connell J, Luan J, Elliott A, McCarroll SA, Roccasecca RM, Pattou F, Sethupathy P, Ariyurek Y, Barter P, Beilby JP, Ben-Shlomo Y, Bergmann S, Bochud M, Bonnefond A, Borch-Johnsen K, Böttcher Y, Brunner E, Bumpstead SJ, Chen YD, Chines P, Clarke R, Coin LJ, Cooper MN, Crisponi L, Day IN, de Geus EJ, Delplanque J, Fedson AC, Fischer-Rosinsky A, Forouhi NG, Franzosi MG, Galan P, Goodarzi MO, Graessler J, Grundy S, Gwilliam R, Hallmans G, Hammond N, Han X, Hartikainen AL, Hayward C, Heath SC, Hercberg S, Hillman DR, Hingorani AD, Hui J, Hung J, Kaakinen M, Kaprio J, Kesaniemi YA, Kivimaki M, Knight B, Koskinen S, Kovacs P, Kyvik KO, Lathrop GM, Lawlor DA, Le Bacquer O, Lecoeur C, Li Y, Mahley R, Mangino M, Martínez-Larrad MT, McAteer JB, McPherson R, Meisinger C, Melzer D, Meyre D, Mitchell BD, Mukherjee S, Naitza S, Neville MJ, Orrù M, Pakyz R, Paolisso G, Pattaro C, Pearson D, Peden JF, Pedersen NL, Pfeiffer AF, Pichler I, Polasek O, Posthuma D, Potter SC, Pouta A, Province MA, Rayner NW, Rice K, Ripatti S, Rivadeneira F, Rolandsson O, Sandbaek A, Sandhu M, Sanna S, Sayer AA, Scheet P, Seedorf U, Sharp SJ, Shields B, Sigurðsson G, Sijbrands EJ, Silveira A, Simpson L, Singleton A, Smith NL, Sovio U, Swift A, Syddall H, Syvänen AC, Tönjes A, Uitterlinden AG, van Dijk KW, Varma D, Visvikis-Siest S, Vitart V, Vogelzangs N, Waeber G, Wagner PJ, Walley A, Ward KL, Watkins H, Wild SH, Willemsen G, Witteman JC, Yarnell JW, Zelenika D, Zethelius B, Zhai G, Zhao JH, Zillikens MC; DIAGRAM Consortium; GIANT Consortium; Global B Pgen Consortium, Borecki IB, Meneton P, Magnusson PK, Nathan DM, Williams GH, Silander K, Bornstein SR, Schwarz P, Spranger J, Karpe F, Shuldiner AR, Cooper C, Serrano-Ríos M, Lind L, Palmer LJ, Hu FB 1st, Franks PW, Ebrahim S, Marmot M, Kao WH, Pramstaller PP, Wright AF, Stumvoll M, Hamsten A; Procardis Consortium, Buchanan TA, Valle TT, Rotter JI, Penninx BW, Boomsma DI, Cao A, Scuteri A, Schlessinger D, Uda M, Ruokonen A, Jarvelin MR, Peltonen L, Mooser V, Sladek R; MAGIC investigators; GLGC Consortium, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Chasman DI, Johansen CT, Fouchier SW, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Feitosa MF, Orho-Melander M, Melander O, Li X, Li M, Cho YS, Go MJ, Kim YJ, Lee JY, Park T, Kim K, Sim X, Ong RT, Croteau-Chonka DC, Lange LA, Smith JD, Ziegler A, Zhang W, Zee RY, Whitfield JB, Thompson JR, Surakka I, Spector TD, Smit JH, Sinisalo J, Scott J, Saharinen J, Sabatti C, Rose LM, Roberts R, Rieder M, Parker AN, Pare G, O’Donnell CJ, Nieminen MS, Nickerson DA, Montgomery GW, McArdle W, Masson D, Martin NG, Marroni F, Lucas G, Luben R, Lokki ML, Lettre G, Launer LJ, Lakatta EG, Laaksonen R, Kyvik KO, König IR, Khaw KT, Kaplan LM, Johansson Å, Janssens AC, Igl W, Hovingh GK, Hengstenberg C, Havulinna AS, Hastie ND, Harris TB, Haritunians T, Hall AS, Groop LC, Gonzalez E, Freimer NB, Erdmann J, Ejebe KG, Döring A, Dominiczak AF, Demissie S, Deloukas P, de Faire U, Crawford G, Chen YD, Caulfield MJ, Boekholdt SM, Assimes TL, Quertermous T, Seielstad M, Wong TY, Tai ES, Feranil AB, Kuzawa CW, Taylor HA Jr, Gabriel SB, Holm H, Gudnason V, Krauss RM, Ordovas JM, Munroe PB, Kooner JS, Tall AR, Hegele RA, Kastelein JJ, Schadt EE, Strachan DP, Reilly MP, Samani NJ, Schunkert H, Cupples LA, Sandhu MS, Ridker PM, Rader DJ, Kathiresan S.
    Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
    PLoS Genet.2012;8(3):e1002607
  • Perry JR, Voight BF, Yengo L, Amin N, Dupuis J, Ganser M, Grallert H, Navarro P, Li M, Qi L, Steinthorsdottir V, Scott RA, Almgren P, Arking DE, Aulchenko Y, Balkau B, Benediktsson R, Bergman RN, Boerwinkle E,Bonnycastle L, Burtt NP, Campbell H, Charpentier G, Collins FS, Gieger C, Green T,  Hadjadj S, Hattersley AT,Herder C, Hofman A, Johnson AD, Kottgen A, Kraft P, Labrune Y, Langenberg C, Manning AK, Mohlke KL,Morris AP, Oostra B, Pankow J, Petersen AK, Pramstaller PP, Prokopenko I, Rathmann W, Rayner W, Roden M, Rudan I, Rybin D, Scott LJ, Sigurdsson G, Sladek R, Thorleifsson G, Thorsteinsdottir U, Tuomilehto J,Uitterlinden AG, Vivequin S, Weedon MN, Wright AF; MAGIC; DIAGRAM Consortium; GIANT Consortium, Hu FB, Illig T, Kao L, Meigs JB, Wilson JF, Stefansson K, van Duijn C, Altschuler D, Morris AD, Boehnke M,McCarthy MI, Froguel P, Palmer CN, Wareham NJ, Groop L, Frayling TM, Cauchi S.
    Stratifying Type 2 Diabetes Cases by BMI Identifies Genetic Risk Variants in LAMA1 and Enrichment for Risk Variants in Lean Compared to Obese Cases
    PLoS Genet.2012 May;8(5):e1002741
  • Miot A, Ragot S, Hammi W, Saulnier PJ, Sosner P, Piguel X, Torremocha F, Marechaud R, Hadjadj S
    Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort.
    Diabetes Care2012 Oct;35(10):2069-75. Epub 2012 Jul 18.
  • Bonnefond A, Yengo L, Philippe J, Dechaume A, Ezzidi I, Vaillant E, Gjesing AP, Andersson EA, Czernichow S, Hercberg S,  Hadjadj S, Charpentier G, Lantieri O,Balkau B, Marre M, Pedersen O, Hansen T, Froguel P, Vaxillaire M.
    Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes.
    Diabetologia2012 Dec 6. [Epub ahead of print]
  • D. Montaigne, O. Bailloeuil, C. Hulin-Delmotte, J.L. Edme, P. Sosner, A. Miot, S. Ragot, P.J. Saulnier, O. Dupuy, P. Gourdy, P. Lecomte, B. Guerci, D. Dardari, R. Roussel, R. Neviere, D. Lacroix, S. Hadjadj, on behalf of the DIAB2NEPHROGENE and SURDIAGENE study groups
    Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patients
    International Journal of Cardiology2012 Aug 9;159(1):63-6.
  • Gaud MA, Frasquet-Darrieux M, Ingrand P, Hankard R, Glomot F, Christin P, Compain F, Bucco C, Pierre F.
    Gestational weight gain: arguments for a transgenerational weight-control process.
    Am J Clin Nutr2012 Feb;95(2):529; author reply 529-31
  • Tang M, Foo J, Gonen M, Guilhot J, Mahon FX, Michor F.
    Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.
    Haematologica2012 Oct;97(10):1553-61
  • Guilhot F, Hughes TP, Cortes J, Druker BJ, Baccarani M, Gathmann I, Hayes M, Granvil C, Wang Y.
    Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial.
    Haematologica. 2012 May;97(5):731-8.
  • Jaafari N, de la Cruz LF, Grau M, Knowles E, Radua J, Wooderson S, Segalas C, Alonso P, Phillips ML, Menchón JM, Mataix-Cols D.
    Neurological soft signs in obsessive-compulsive disorder: two empirical studies and meta-analysis.
    Psychol Med. 2012 Aug 30:1-11.
  • Rochelle T, Daubon T, Van Troys M, Harnois T, Waterschoot D, Ampe C, Roy L, Bourmeyster N, Constantin B.
    p210bcr-abl induces amoeboid motility by recruiting ADF/destrin through RhoA/ROCK1.
    FASEB J2012 Oct 9. [Epub ahead of print]
  • Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S.
    Synthesis and Antitumor Efficacy of a a-Glucuronidase-Responsive Albumin-Binding Prodrug of Doxorubicin.
    J Med Chem.2012 May 10;55(9):4516-20.
  • Guilhot F, Roy L, Tomowiak C.
    Current treatment strategies in chronic myeloid leukemia.
    Curr Opin Hematol.2012 Mar;19(2):102-9
  • Couturier J, Paccalin M, Lafay-Chebassier C, Chalon S, Ingrand I, Pinguet J, Pontcharraud R, Guillard O, Fauconneau B, Page G
    Pharmacological inhibition of the double-stranded RNA-dependent protein kinase prevents long-term inflammation in APPswePS1dE9 mice but increases amyloid burden at advanced stages of Alzheimer’s disease
    Current Alzheimer Research2012 Mar;9(3):344-60
  • Rossignol A, Levescot A, Jacomet F, Robin A, Basbous S, Giraud C, Roy L, Guilhot F, Turhan AG, Barra A, Herbelin A, Gombert JM.
    Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
    Eur J Immunol2012 Jul;42(7):1870-5
  • Landré L, Destrieux C, Andersson F, Barantin L, Quidé Y, Tapia G, Jaafari N, Clarys D, Gaillard P, Isingrini M, El-Hage W.
    Working memory processing of traumatic material in women with posttraumatic stress disorder.
    J Psychiatry Neurosci2012 Feb;37(2):87-94
  • Tchang JH, Paik SY, Mao L, Eisner W, Flannery PJ, Wang L, Tang Y, Mattocks N, Hadjadj S, Goujon JM, Ruiz P, Gurley SB, Spurney RF.
    Diabetic Kidney Disease in FVB/NJ Akita Mice: Temporal Pattern of Kidney Injury and Urinary Nephrin Excretion
    PLoS One2012;7(4):e33942
  • Palmer ND, McDonough CW, Hadjadj S, Hicks PJ, Roh BH, Wing MR, An SS, Hester JM, Cooke JN
    A genome-wide association search for type 2 diabetes genes in African Americans.
    PLoS One2012;7(1):e29202
  • Arroyo-Anlló EM, Bellouard S, Ingrand P, Gil R.
    Effects of Automatic/Controlled Access Processes on Semantic Memory in Alzheimer’s Disease
    J Alzheimers Dis2011;25(3):525-33
  • Lamiche C, Clarhaut J, Strale PO, Crespin S, Pedretti N, Bernard FX, Naus CC, Chen VC, Foster LJ, Defamie N, Mesnil M, Debiais F, Cronier L.
    The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells.
    Clin Exp Metastasis.2012 Feb;29(2):111-22
  • Letellier G, Mok E, Alberti C, De Luca A, Gottrand F, Cuisset JM, Denjean A, Darmaun D, Hankard R.
    Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy.
    Clin Nutr. 2012 Sep 14. pii: S0261-5614(12)00186-0
  • Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M, Defamie N.
    Down-regulation of connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion.
    Mol Carcinog2012 Nov;51(11):845-60
  • de Luca A, Boisseau N, Tea I, Louvet I, Robins RJ, Forhan A, Charles MA, Hankard R.
    d(15)N and d(13)C in hair from newborn infants and their mothers: a cohort study.
    Pediatr Res.2012 May;71(5):598-604
  • Legendre G, Ringa V, Fauconnier A, Fritel X.
    Menopause, hormone treatment and urinary incontinence at midlife.
    Maturitas2013 Jan;74(1):26-30
  • Gater A, Heron L, Abetz-Webb L, Coombs J, Simmons J, Guilhot F, Rea D.
    Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia.
    Leuk Res2012 Jul;36(7):817-25
  • Ingrand I, Houeto JL, Gil R, Mc Gee H, Ingrand P, Paccalin M.
    The validation of a French-language version of the Aging Perceptions Questionnaire (APQ) and its extension to a population aged 55 and over.
    BMC Geriatr.2012 Apr 30;12:17
  • Bloch F, Thibaud M, Tournoux-Facon C, Brèque C, Rigaud AS, Dugué B, Kemoun G.
    Estimation of the risk factors for falls in the elderly: Can meta-analysis provide a valid answer?
    GERIATR GERONTOL INT2012 Nov 27.
  • Oriot D, Darrieux E, Boureau-Voultoury A, Ragot S, Scépi M.
    Validation of a Performance Assessment Scale for Simulated Intraosseous Access.
    Simul Healthc2012 Jun;7(3):171-5
  • Tournoux-Facon C, Robinet G, Pinel MC, Ferre P, Tourani JM.
    Phase I and Pharmacokinetic Study of IV Vinflunine in Combination With Carboplatin in Chemonaive Patients With Advanced Non-small Cell Lung Cancer.
    J Clin Oncol. 2012 Aug;35(4):378-85
  • Fritel X, Ringa V, Quiboeuf E, Fauconnier A.
    Female urinary incontinence, from pregnancy to menopause: a review of epidemiological and pathophysiological findings
    Acta Obstet Gynecol Scand.2012 Aug;91(8):901-10
  • Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, Ingrand P, Gilbert B, Godenèche G, Neau JP.
    Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation.
    Clin Neurol Neurosurg.2012 Apr;114(3):235-40
  • Frédéric K, Cyril B, Hugues PM, Stéphanie R, Caroline H, Jean Pierre R, Michel S.
    Intervertebral Foramen Variation Following Dynamic L4-L5 Interspinal Device Implantation: Foramen Size After Interspinal Device Implantation.
    J Spinal Disord Tech2012 Nov 22. [Epub ahead of print]
  • Souviat C, Bricou A, Porcher R, Demaria F, Fritel X, Benifla JL, Pigné A.
    Long-term functional stability of sacrospinous ligament-fixation repair of pelvic organ prolapse.
    J Obstet Gynaecol2012 Nov;32(8):781-5.
  • De Luca A, Piloquet H, Mansilla M, Simon D, Fischbach M, Caldari D, Dorigny B, Ingrand P, Hankard R.
    Multicenter nutritional screening in hospitalized children.
    Arch Pediatr2012 May;19(5):545-6
  • D. Montaigne, O. Bailloeuil, C. Hulin-Delmotte, J.L. Edme, P. Sosner, A. Miot, S. Ragot, P.J. Saulnier, O. Dupuy, P. Gourdy, P. Lecomte, B. Guerci, D. Dardari, R. Roussel, R. Neviere, D. Lacroix, S. Hadjadj, on behalf of the DIAB2NEPHROGENE and SURDIAGENE study groups
    Renal complications correlate with electrical atrial vulnerability hallmarks in type 2 diabetic patientsInternational
    SFD 2012 Nice France
  • PJ Saulnier Y Gallois, S Ragot, P Gourdy, F Bonnet, G Charpentier, O Dupuy,B Guerci, G Guilloteau, P Lecomte, F Rachedi1 R Roussel, A Sechet O Verier-Mine, M Marre, R Marechaud, S Hadjadj for the DIAB2NEPHROGENE study group.
    Impact of sex hormones and of aromatase gene variants on diabetic nephropathy in type 2 diabetes.
    EDNSG meeting 2012 Dublin Ireland
  • Miot, A; Ragot, S ; Hammi, W ; Saulnier, PJ; Sosner, P ; Piguel, X ; Marechaud, R; Hadjadj, S
    Prognostic value of cardiac frequency in cardiovascular and renal risk events in type 2 diabetic patients: prospective study.
    SFD 2012 Nice France
  • Quiboeuf E, Saurel MJ, Fritel X.
    Evolution of urinary incontinence in women between 4 and 24 months postpartum in the cohort EDEN.
    ICS 2012, Beijing, China.
  • Quiboeuf E, Saurel MJ, Fritel X.
    Evolution de l’incontinence urinaire chez la femme entre 4 et 24 mois post-partum dans la cohorte EDEN.
    SIFUD-PP 2012, Clermont-Ferrand, France.
  • Fritel X, Fauconnier A, Savary D, Letouzey V, Gueye A, Campagne S, Bader G, Cotte L, Fianu A, Fernandez H, Guilhot-Gaudeffroy J, de Tayrac R.
    Prevent postnatal urinary incontinence by prenatal pelvic floor muscle training? First results of the multicenter randomized study 3PN, PreNatal Pelvic floor Prevention.
    ICS 2012, Beijing, China.
  • Fritel X, Fauconnier A, Savary D, Letouzey V, Gueye A, Campagne S, Bader G, Deffieux X, Cotte L, Richet C, Fianu A, Fernandez H, Guilhot-Gaudeffroy J, de Tayrac R.
    Prévenir l’incontinence urinaire postnatale par la rééducation périnéale prénatale ? Premiers résultats de l’étude randomisée multicentrique 3PN, Prévention Périnéale PréNatale.
    SIFUD-PP 2012, Clermont-Ferrand, France.
  • Rea D, Rousselot P, Guilhot J, Guilhot F, Mahon FX.
    Curing chronic myeloid leukemia.
    Curr Hematol Malig Rep.2012 Jun;7(2):103-8.
  • Baudemont C, Merlet I, Boisgueheneuc FD, Liuu E, Tartarin F,  Ragot S Paccalin M.
    Cognitive-behavioral specialized units: predictive factors of readmissions within three months.
    Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep 1;10(3):277-283.
  • M Grinda, J Clarhaut, B Renoux, I Tranoy-Opalinskia, S Papot
    A self-immolative dendritic glucuronide prodrug of doxorubicinMed.
    Chem. Commun